UMMS Affiliation
Department of Medicine, Division of Infectious Diseases and Immunology; Department of Medicine, Division of Preventive and Behavioral Medicine
Publication Date
11-9-2010
Document Type
Article
Subjects
AIDS Vaccines; Antibodies, Neutralizing; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans
Disciplines
Immunology and Infectious Disease | Life Sciences | Medicine and Health Sciences
Abstract
In the current report, we compared the specificities of antibody responses in sera from volunteers enrolled in three US NIH-supported HIV vaccine trials using different immunization regimens. HIV-1 Env-specific binding antibody, neutralizing antibody, antibody-dependent cell-mediated cytotoxicity (ADCC), and profiles of antibody specificity were analyzed for human immune sera collected from vaccinees enrolled in the NIH HIV Vaccine Trial Network (HVTN) Study #041 (recombinant protein alone), HVTN Study #203 (poxviral vector prime-protein boost), and the DP6-001 study (DNA prime-protein boost). Vaccinees from HVTN Study #041 had the highest neutralizing antibody activities against the sensitive virus along with the highest binding antibody responses, particularly those directed toward the V3 loop. DP6-001 sera showed a higher frequency of positive neutralizing antibody activities against more resistant viral isolate with a significantly higher CD4 binding site (CD4bs) antibody response compared to both HVTN studies #041 and #203. No differences were found in CD4-induced (CD4i) antibody responses, ADCC activity, or complement activation by Env-specific antibody among these sera. Given recent renewed interest in realizing the importance of antibody responses for next generation HIV vaccine development, different antibody profiles shown in the current report, based on the analysis of a wide range of antibody parameters, provide critical biomarker information for the selection of HIV vaccines for more advanced human studies and, in particular, those that can elicit antibodies targeting conformational-sensitive and functionally conserved epitopes.
Rights and Permissions
Copyright: © 2010 Vaine et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
DOI of Published Version
10.1371/journal.pone.0013916
Source
Vaine M, Wang S, Liu Q, Arthos J, Montefiori D, et al. (2010) Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies. PLoS ONE 5(11): e13916. doi:10.1371/journal.pone.0013916. Link to article on publisher's site
Journal/Book/Conference Title
PloS one
Related Resources
PubMed ID
21085486
Repository Citation
Vaine, Michael; Wang, Shixia; Liu, Qin; Arthos, James; Montefiori, David C.; Goepfert, Paul; McElrath, M. Juliana; and Lu, Shan, "Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies" (2010). Open Access Articles. 2362.
https://escholarship.umassmed.edu/oapubs/2362